INVA vs VNO · P/E 3.6, rev $217.6M vs rev $921.3M
Innoviva Inc (INVA) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Innoviva Inc (INVA) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported INVA revenue for 2026-06-30 was $217.6M. Net income was $103.2M. INVA currently screens at market cap $1.66B and trailing P/E 3.6.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
INVA currently screens at market cap $1.66B and trailing P/E 3.6. VNO currently screens at market cap $0.
Not investment advice. Open the INVA and VNO stock pages for the full models.
Not investment advice.